These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28855)

  • 1. Reactions of K-region oxides of carcinogenic and noncarcinogenic aromatic hydrocarbons. Comparative studies on reactions with nucleophiles and acid-catalyzed reactions.
    Okamoto T; Shudo K; Miyata N; Kitahara Y; Nagata S
    Chem Pharm Bull (Tokyo); 1978 Jul; 26(7):2014-6. PubMed ID: 28855
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactions of the K-region oxides of carcinogenic and related polycyclic hydrocarbons with nucleophiles: stereochemistry and regioselectivity.
    Beland FA; Harvey RG
    J Am Chem Soc; 1976 Aug; 98(16):4963-70. PubMed ID: 950418
    [No Abstract]   [Full Text] [Related]  

  • 3. "K-region" oxides and related oxidized metabolites of carcinogenic aromatic hydrocarbons.
    Harvey RG; Goh SH; Cortez C
    J Am Chem Soc; 1975 Jun; 97(12):3468-79. PubMed ID: 1141576
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of K- and non-K-region arene oxides and phenols of polycyclic hydrocarbons to polyguanylic acid.
    Blobstein SH; Weinstein IB; Dansette P; Yagi H; Jerina DM
    Cancer Res; 1976 Apr; 36(4):1293-8. PubMed ID: 816462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons.
    Sayer JM; Whalen DL; Jerina DM
    Drug Metab Rev; 1989; 20(2-4):155-82. PubMed ID: 2680377
    [No Abstract]   [Full Text] [Related]  

  • 6. Polycyclic k-region arene oxides. Products and kinetics of solvolysis.
    Keller JW; Heidelberger C
    J Am Chem Soc; 1976 Apr; 98(8):2328-36. PubMed ID: 1254869
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative reactivities of diolepoxide metabolites of carcinogenic hydrocarbons with phiX174 viral DNA.
    Hsu WT; Lin EJ; Fu PP; Harvey RG; Weiss SB
    Biochem Biophys Res Commun; 1979 May; 88(1):251-7. PubMed ID: 378230
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenic and carcinogenic properties of polycyclic aromatic hydrocarbons.
    Pashin YV; Bakhitova LM
    Environ Health Perspect; 1979 Jun; 30():185-9. PubMed ID: 446450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
    Adams SM; Kaminsky LS
    Mol Pharmacol; 1982 Sep; 22(2):459-64. PubMed ID: 7144738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis.
    Sims P; Grover PL
    Adv Cancer Res; 1974; 20():165-274. PubMed ID: 4617500
    [No Abstract]   [Full Text] [Related]  

  • 12. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclopenta-polycyclic aromatic hydrocarbons: potential carcinogens and mutagens.
    Fu PP; Beland FA; Yang SK
    Carcinogenesis; 1980 Aug; 1(8):725-7. PubMed ID: 11272127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons.
    Jerina DM; Sayer JM; Agarwal SK; Yagi H; Levin W; Wood AW; Conney AH; Pruess-Schwartz D; Baird WM; Pigott MA
    Adv Exp Med Biol; 1986; 197():11-30. PubMed ID: 3490131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POLYCYCLIC HYDROCARBONS.
    BOYLAND E
    Br Med Bull; 1964 May; 20():121-6. PubMed ID: 14169949
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on chemical carcinogens. XXI. Quantitative structure-mutagenicity relationship among substituted styrene oxides.
    Tamura N; Takahashi K; Shirai N; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1393-400. PubMed ID: 7049420
    [No Abstract]   [Full Text] [Related]  

  • 17. Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens.
    Ames BN; Sims P; Grover PL
    Science; 1972 Apr; 176(4030):47-9. PubMed ID: 4551487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of epoxides and epoxy compounds.
    Hemminki K; Vainio H
    Prog Clin Biol Res; 1984; 141():373-84. PubMed ID: 6718385
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical and mutagenic specificities of polycyclic aromatic hydrocarbon carcinogens.
    Dipple A; Peltonen K; Cheng SC; Ross H; Bigger CA
    Adv Exp Med Biol; 1994; 354():101-12. PubMed ID: 8067279
    [No Abstract]   [Full Text] [Related]  

  • 20. Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds.
    Daly JW; Jerina DM; Witkop B
    Experientia; 1972 Oct; 28(10):1129-49. PubMed ID: 4117670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.